Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,620 | 35 | 68.1% |
| Travel and Lodging | $757.98 | 1 | 31.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GE HEALTHCARE | $1,304 | 11 | $0 (2020) |
| Cianna Medical Inc | $674.55 | 5 | $0 (2018) |
| Myriad Genetic Laboratories, Inc. | $137.52 | 8 | $0 (2024) |
| Bard Peripheral Vascular, Inc. | $57.05 | 3 | $0 (2017) |
| Volpara Solutions Inc | $49.37 | 3 | $0 (2017) |
| Molli Surgical (us) Inc | $42.37 | 1 | $0 (2024) |
| Merck Sharp & Dohme LLC | $40.52 | 2 | $0 (2022) |
| Focal Therapeutics, Inc. | $37.76 | 1 | $0 (2017) |
| Medtronic USA, Inc. | $23.22 | 1 | $0 (2017) |
| HOLOGIC INC | $12.31 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $87.39 | 4 | Myriad Genetic Laboratories, Inc. ($45.02) |
| 2023 | $20.64 | 1 | Myriad Genetic Laboratories, Inc. ($20.64) |
| 2022 | $23.14 | 1 | Merck Sharp & Dohme LLC ($23.14) |
| 2021 | $89.24 | 5 | Myriad Genetic Laboratories, Inc. ($71.86) |
| 2020 | $91.41 | 1 | GE HEALTHCARE ($91.41) |
| 2019 | $210.70 | 2 | GE HEALTHCARE ($210.70) |
| 2018 | $427.00 | 4 | Cianna Medical Inc ($378.38) |
| 2017 | $1,429 | 18 | GE HEALTHCARE ($952.90) |
All Payment Transactions
36 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/04/2024 | Myriad Genetic Laboratories, Inc. | MYRISK (Device) | Food and Beverage | In-kind items and services | $15.69 | General |
| Category: ONCOLOGY | ||||||
| 04/24/2024 | Molli Surgical (us) Inc | — | Food and Beverage | In-kind items and services | $42.37 | General |
| 04/16/2024 | Myriad Genetic Laboratories, Inc. | MYRISK (Device) | Food and Beverage | In-kind items and services | $14.09 | General |
| Category: ONCOLOGY | ||||||
| 02/15/2024 | Myriad Genetic Laboratories, Inc. | MYRISK (Device) | Food and Beverage | In-kind items and services | $15.24 | General |
| Category: ONCOLOGY | ||||||
| 06/06/2023 | Myriad Genetic Laboratories, Inc. | BRACANALYSIS CDX (Device) | Food and Beverage | In-kind items and services | $20.64 | General |
| Category: ONCOLOGY | ||||||
| 05/19/2022 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $23.14 | General |
| Category: ONCOLOGY | ||||||
| 10/05/2021 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $17.38 | General |
| Category: ONCOLOGY | ||||||
| 06/17/2021 | Myriad Genetic Laboratories, Inc. | myRisk (Device) | Food and Beverage | Cash or cash equivalent | $15.19 | General |
| Category: Germline DNA Sequencing Hereditary Cancer and Rearrangement Analysis | ||||||
| 05/25/2021 | Myriad Genetic Laboratories, Inc. | BRACAnalysis (Device) | Food and Beverage | Cash or cash equivalent | $18.30 | General |
| Category: Germline DNA Sequencing Hereditary Cancer and Rearrangement Analysis | ||||||
| 02/02/2021 | Myriad Genetic Laboratories, Inc. | myRisk (Device) | Food and Beverage | Cash or cash equivalent | $19.51 | General |
| Category: Germline DNA Sequencing Hereditary Cancer and Rearrangement Analysis | ||||||
| 01/19/2021 | Myriad Genetic Laboratories, Inc. | BRACAnalysis (Device) | Food and Beverage | Cash or cash equivalent | $18.86 | General |
| Category: Germline DNA Sequencing Hereditary Cancer and Rearrangement Analysis | ||||||
| 01/08/2020 | GE HEALTHCARE | — | Food and Beverage | Cash or cash equivalent | $91.41 | General |
| 12/01/2019 | GE HEALTHCARE | — | Food and Beverage | Cash or cash equivalent | $79.12 | General |
| 01/09/2019 | GE HEALTHCARE | — | Food and Beverage | Cash or cash equivalent | $131.58 | General |
| 10/15/2018 | GE Healthcare | — | Food and Beverage | Cash or cash equivalent | $48.62 | General |
| 07/24/2018 | Cianna Medical Inc | SAVI/SAVI SCOUT (Device) | Food and Beverage | Cash or cash equivalent | $241.77 | General |
| Category: Breast Cancer Medical Device | ||||||
| 07/24/2018 | Cianna Medical Inc | SAVI/SAVI SCOUT (Device) | Food and Beverage | Cash or cash equivalent | $110.00 | General |
| Category: Breast Cancer Medical Device | ||||||
| 03/22/2018 | Cianna Medical Inc | SAVI/SAVI SCOUT (Device) | Food and Beverage | Cash or cash equivalent | $26.61 | General |
| Category: Breast Cancer Medical Device | ||||||
| 11/08/2017 | Cianna Medical Inc | SAVI/SAVI SCOUT (Device) | Food and Beverage | Cash or cash equivalent | $216.02 | General |
| Category: Breast Cancer Medical Device | ||||||
| 11/08/2017 | Bard Peripheral Vascular, Inc. | BPV-Marquee (Device) | Food and Beverage | Cash or cash equivalent | $15.22 | General |
| Category: Vascular | ||||||
| 11/06/2017 | Medtronic USA, Inc. | Intact (Device) | Food and Beverage | In-kind items and services | $23.22 | General |
| Category: Advanced Energy Biopsy Device | ||||||
| 10/04/2017 | HOLOGIC INC | Brevera (Device) | Food and Beverage | In-kind items and services | $12.31 | General |
| Category: Breast and Skeletal | ||||||
| 09/27/2017 | Volpara Solutions Inc | — | Food and Beverage | Cash or cash equivalent | $15.10 | General |
| 08/29/2017 | Bard Peripheral Vascular, Inc. | BPV-Marquee (Device) | Food and Beverage | Cash or cash equivalent | $21.21 | General |
| Category: Vascular | ||||||
| 08/09/2017 | Focal Therapeutics, Inc. | BioZorb (Device) | Food and Beverage | In-kind items and services | $37.76 | General |
| Category: Tissue Marker | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 6,500 | 6,632 | $821,350 | $209,198 |
| 2022 | 12 | 6,779 | 7,238 | $1.2M | $226,888 |
| 2021 | 13 | 6,860 | 7,552 | $1.2M | $234,284 |
| 2020 | 12 | 6,352 | 6,913 | $1.1M | $221,958 |
All Medicare Procedures & Services
54 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 77067 | Screening mammography | Facility | 2023 | 2,275 | 2,275 | $299,025 | $79,738 | 26.7% |
| 77063 | Screening 3d breast mammography | Facility | 2023 | 2,282 | 2,282 | $205,890 | $63,747 | 31.0% |
| 76641 | Complete ultrasound scan of 1 breast | Facility | 2023 | 627 | 654 | $112,445 | $20,769 | 18.5% |
| 77065 | Diagnostic mammography of 1 breast | Facility | 2023 | 222 | 283 | $42,985 | $7,386 | 17.2% |
| 77067 | Screening mammography | Office | 2023 | 48 | 48 | $26,160 | $6,452 | 24.7% |
| 19083 | Biopsy of breast and placement of locating device using ultrasound, first growth | Facility | 2023 | 54 | 54 | $26,586 | $6,299 | 23.7% |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | Facility | 2023 | 262 | 297 | $23,640 | $5,930 | 25.1% |
| 77049 | Mri scan of both breasts | Facility | 2023 | 61 | 61 | $22,827 | $4,894 | 21.4% |
| 77066 | Diagnostic mammography of both breasts | Facility | 2023 | 118 | 119 | $21,743 | $3,891 | 17.9% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Facility | 2023 | 361 | 362 | $7,260 | $3,309 | 45.6% |
| 77063 | Screening 3d breast mammography | Office | 2023 | 43 | 43 | $12,685 | $2,360 | 18.6% |
| 76642 | Limited ultrasound scan of 1 breast | Facility | 2023 | 96 | 102 | $10,836 | $2,269 | 20.9% |
| 19285 | Placement of locating device in breast using ultrasound guidance, first growth | Facility | 2023 | 29 | 29 | $8,532 | $1,895 | 22.2% |
| 76098 | X-ray of surgical specimen | Facility | 2023 | 22 | 23 | $736.00 | $258.06 | 35.1% |
| 77067 | Screening mammography | Facility | 2022 | 2,403 | 2,403 | $445,905 | $85,221 | 19.1% |
| 77063 | Screening 3d breast mammography | Facility | 2022 | 2,408 | 2,410 | $287,760 | $68,611 | 23.8% |
| 76641 | Complete ultrasound scan of 1 breast | Facility | 2022 | 696 | 1,007 | $179,365 | $26,664 | 14.9% |
| 77065 | Diagnostic mammography of 1 breast | Facility | 2022 | 304 | 386 | $74,324 | $10,616 | 14.3% |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | Facility | 2022 | 395 | 448 | $40,320 | $9,374 | 23.2% |
| 77066 | Diagnostic mammography of both breasts | Facility | 2022 | 188 | 191 | $43,847 | $6,360 | 14.5% |
| 19083 | Biopsy of breast and placement of locating device using ultrasound, first growth | Facility | 2022 | 43 | 45 | $28,575 | $5,344 | 18.7% |
| 77067 | Screening mammography | Office | 2022 | 122 | 122 | $22,242 | $4,442 | 20.0% |
| 77049 | Mri scan of both breasts | Facility | 2022 | 48 | 49 | $23,079 | $3,971 | 17.2% |
| 76642 | Limited ultrasound scan of 1 breast | Facility | 2022 | 104 | 108 | $14,688 | $2,377 | 16.2% |
| 19285 | Placement of locating device in breast using ultrasound guidance, first growth | Facility | 2022 | 31 | 31 | $11,098 | $2,059 | 18.6% |
About Dr. John Cutrone, M.D
Dr. John Cutrone, M.D is a Diagnostic Radiology healthcare provider based in Columbus, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1306860127.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Cutrone, M.D has received a total of $2,378 in payments from pharmaceutical and medical device companies, with $87.39 received in 2024. These payments were reported across 36 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($1,620).
As a Medicare-enrolled provider, Cutrone has provided services to 26,491 Medicare beneficiaries, totaling 28,335 services with total Medicare billing of $892,327. Data is available for 4 years (2020–2023), covering 54 distinct procedure/service records.
Practice Information
- Specialty Diagnostic Radiology
- Location Columbus, GA
- Active Since 07/26/2006
- Last Updated 04/25/2023
- Taxonomy Code 2085R0202X
- Entity Type Individual
- NPI Number 1306860127
Products in Payments
- VSCAN (Device) $757.98
- SAVI/SAVI SCOUT (Device) $674.55
- BPV-Marquee (Device) $57.05
- MYRISK (Device) $45.02
- KEYTRUDA (Biological) $40.52
- BioZorb (Device) $37.76
- BRACAnalysis (Device) $37.16
- myRisk (Device) $34.70
- Intact (Device) $23.22
- BRACANALYSIS CDX (Device) $20.64
- Brevera (Device) $12.31
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Diagnostic Radiology Doctors in Columbus
Peter Pema, Md, MD
Diagnostic Radiology — Payments: $388,528
J Mcgraw, Md, MD
Diagnostic Radiology — Payments: $241,386
Mamdouh Khayat, Md, MD
Diagnostic Radiology — Payments: $144,952
Dr. Cameron Kersey, M.d, M.D
Diagnostic Radiology — Payments: $134,063
Dr. Jeffrey Hawley, Md, MD
Diagnostic Radiology — Payments: $68,290
Peter Lafferty, M.d, M.D
Diagnostic Radiology — Payments: $31,820